Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock

Recursion Pharmaceuticals ( RXRX +1.27%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...
How-To Geek on MSN

7 unusual programming languages that are worth taking a look at

By any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...

Recursion Pharmaceuticals: Q3 Earnings Snapshot

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a ...
The Caledonian-Record

Recursion Announces CEO Transition Plan to Drive Next Phase of Growth

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

3 Things Investors Need to Know About Recursion Pharmaceuticals

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...
IEEE

Linear and Widely Linear Recursive Maximum Complex-Domain Loglikelihood Adaptive Filtering in Intricate Measurement Environments

Abstract: In industrial measurements, when signal reception is affected by hardware defects or asymmetric interference, I/Q imbalance can occur, which may result in the noise exhibiting noncircular ...
Investing

Recursion Pharma CEO Gibson sells $570,000 in shares

Recursion Pharmaceuticals NASDAQ:RXRX Chief Executive Officer Christopher Gibson sold 100,000 shares of Class A Common Stock on October 23, 2025, at a price of $5.70, totaling $570,000. The sale ...
Yahoo Finance

Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $5.75, demonstrating a -5.89% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily ...